Recent achievements in CAR-T cell immunotherapy for glioblastoma treatment
Glioblastoma remains the most common and aggressive primary brain tumor today. Because of the neuroanatomical location of glioblastoma, conventional chemotherapy and radiation therapy have limited efficacy in patients with these tumors. Over the past decade, antitumor immunotherapy has become widesp...
Enregistré dans:
Auteurs principaux: | S. V. Timofeeva, A. O. Sitkovskaya, I. A. Novikova, M. A. Ezhova, E. P. Lysenko, O. I. Kit |
---|---|
Format: | article |
Langue: | RU |
Publié: |
SPb RAACI
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/bc84923f84924863a08fac30e16a46d8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Optimizatsiya i intensifikatsiya insulinoterapii pri sakharnom diabete 2 tipa (klinicheskie rekomendatsii)
par: Ivan Ivanovich Dedov, et autres
Publié: (2010) -
Aptamer-Conjugated Gold Nanoparticles Targeting Epidermal Growth Factor Receptor Variant III for the Treatment of Glioblastoma
par: Peng L, et autres
Publié: (2020) -
Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
par: Sergey Kulemzin, et autres
Publié: (2021) -
DEVELOPMENT OF A REAL-TIME RT-PCR-BASED TEST PANEL FOR ASSESSMENT OF CYTOKINE PROFILE IN MONONUCLEAR CELLS FROM BLOOD AND SYNOVIAL FLUID IN RHEUMATOID ARTHRITIS
par: D. Yu. Trofimov, et autres
Publié: (2014) -
Development of approaches for cellular immunotherapy of cancer patients
par: Yu. V. Gelm, et autres
Publié: (2021)